The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tachykinin Receptor 1 Antibody Market Research Report 2025
Synopsis
The global Tachykinin Receptor 1 Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Tachykinin Receptor 1 Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tachykinin Receptor 1 Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Tachykinin Receptor 1 Antibody in Flow Cytometry is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Tachykinin Receptor 1 Antibody include LSBio, Advanced Targeting Solutions, United States Biological, Everest Biotech, NSJ Bioreagents, ProSci, Cusabio, FineTest and GeneTex, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tachykinin Receptor 1 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tachykinin Receptor 1 Antibody.
Report Scope
The Tachykinin Receptor 1 Antibody market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tachykinin Receptor 1 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tachykinin Receptor 1 Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
LSBio
Advanced Targeting Solutions
United States Biological
Everest Biotech
NSJ Bioreagents
ProSci
Cusabio
FineTest
GeneTex
Santa Cruz Biotechnology
Merck
Atlas Antibodies
Proteintech
Boster Biological Technology
Segment by Type
Polyclonal
Monoclonal
Segment by Application
Flow Cytometry
Immunocytochemistry
Immunofluorescence
Western Blot
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tachykinin Receptor 1 Antibody companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Tachykinin Receptor 1 Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Tachykinin Receptor 1 Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tachykinin Receptor 1 Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Tachykinin Receptor 1 Antibody in Flow Cytometry is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Tachykinin Receptor 1 Antibody include LSBio, Advanced Targeting Solutions, United States Biological, Everest Biotech, NSJ Bioreagents, ProSci, Cusabio, FineTest and GeneTex, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tachykinin Receptor 1 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tachykinin Receptor 1 Antibody.
Report Scope
The Tachykinin Receptor 1 Antibody market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tachykinin Receptor 1 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tachykinin Receptor 1 Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
LSBio
Advanced Targeting Solutions
United States Biological
Everest Biotech
NSJ Bioreagents
ProSci
Cusabio
FineTest
GeneTex
Santa Cruz Biotechnology
Merck
Atlas Antibodies
Proteintech
Boster Biological Technology
Segment by Type
Polyclonal
Monoclonal
Segment by Application
Flow Cytometry
Immunocytochemistry
Immunofluorescence
Western Blot
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tachykinin Receptor 1 Antibody companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tachykinin Receptor 1 Antibody Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Polyclonal
1.2.3 Monoclonal
1.3 Market by Application
1.3.1 Global Tachykinin Receptor 1 Antibody Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Flow Cytometry
1.3.3 Immunocytochemistry
1.3.4 Immunofluorescence
1.3.5 Western Blot
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tachykinin Receptor 1 Antibody Market Perspective (2019-2030)
2.2 Tachykinin Receptor 1 Antibody Growth Trends by Region
2.2.1 Global Tachykinin Receptor 1 Antibody Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tachykinin Receptor 1 Antibody Historic Market Size by Region (2019-2024)
2.2.3 Tachykinin Receptor 1 Antibody Forecasted Market Size by Region (2025-2030)
2.3 Tachykinin Receptor 1 Antibody Market Dynamics
2.3.1 Tachykinin Receptor 1 Antibody Industry Trends
2.3.2 Tachykinin Receptor 1 Antibody Market Drivers
2.3.3 Tachykinin Receptor 1 Antibody Market Challenges
2.3.4 Tachykinin Receptor 1 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tachykinin Receptor 1 Antibody Players by Revenue
3.1.1 Global Top Tachykinin Receptor 1 Antibody Players by Revenue (2019-2024)
3.1.2 Global Tachykinin Receptor 1 Antibody Revenue Market Share by Players (2019-2024)
3.2 Global Tachykinin Receptor 1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tachykinin Receptor 1 Antibody Revenue
3.4 Global Tachykinin Receptor 1 Antibody Market Concentration Ratio
3.4.1 Global Tachykinin Receptor 1 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tachykinin Receptor 1 Antibody Revenue in 2023
3.5 Tachykinin Receptor 1 Antibody Key Players Head office and Area Served
3.6 Key Players Tachykinin Receptor 1 Antibody Product Solution and Service
3.7 Date of Enter into Tachykinin Receptor 1 Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tachykinin Receptor 1 Antibody Breakdown Data by Type
4.1 Global Tachykinin Receptor 1 Antibody Historic Market Size by Type (2019-2024)
4.2 Global Tachykinin Receptor 1 Antibody Forecasted Market Size by Type (2025-2030)
5 Tachykinin Receptor 1 Antibody Breakdown Data by Application
5.1 Global Tachykinin Receptor 1 Antibody Historic Market Size by Application (2019-2024)
5.2 Global Tachykinin Receptor 1 Antibody Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tachykinin Receptor 1 Antibody Market Size (2019-2030)
6.2 North America Tachykinin Receptor 1 Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tachykinin Receptor 1 Antibody Market Size by Country (2019-2024)
6.4 North America Tachykinin Receptor 1 Antibody Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tachykinin Receptor 1 Antibody Market Size (2019-2030)
7.2 Europe Tachykinin Receptor 1 Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tachykinin Receptor 1 Antibody Market Size by Country (2019-2024)
7.4 Europe Tachykinin Receptor 1 Antibody Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tachykinin Receptor 1 Antibody Market Size (2019-2030)
8.2 Asia-Pacific Tachykinin Receptor 1 Antibody Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tachykinin Receptor 1 Antibody Market Size by Region (2019-2024)
8.4 Asia-Pacific Tachykinin Receptor 1 Antibody Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tachykinin Receptor 1 Antibody Market Size (2019-2030)
9.2 Latin America Tachykinin Receptor 1 Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tachykinin Receptor 1 Antibody Market Size by Country (2019-2024)
9.4 Latin America Tachykinin Receptor 1 Antibody Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tachykinin Receptor 1 Antibody Market Size (2019-2030)
10.2 Middle East & Africa Tachykinin Receptor 1 Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tachykinin Receptor 1 Antibody Market Size by Country (2019-2024)
10.4 Middle East & Africa Tachykinin Receptor 1 Antibody Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 LSBio
11.1.1 LSBio Company Detail
11.1.2 LSBio Business Overview
11.1.3 LSBio Tachykinin Receptor 1 Antibody Introduction
11.1.4 LSBio Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024)
11.1.5 LSBio Recent Development
11.2 Advanced Targeting Solutions
11.2.1 Advanced Targeting Solutions Company Detail
11.2.2 Advanced Targeting Solutions Business Overview
11.2.3 Advanced Targeting Solutions Tachykinin Receptor 1 Antibody Introduction
11.2.4 Advanced Targeting Solutions Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024)
11.2.5 Advanced Targeting Solutions Recent Development
11.3 United States Biological
11.3.1 United States Biological Company Detail
11.3.2 United States Biological Business Overview
11.3.3 United States Biological Tachykinin Receptor 1 Antibody Introduction
11.3.4 United States Biological Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024)
11.3.5 United States Biological Recent Development
11.4 Everest Biotech
11.4.1 Everest Biotech Company Detail
11.4.2 Everest Biotech Business Overview
11.4.3 Everest Biotech Tachykinin Receptor 1 Antibody Introduction
11.4.4 Everest Biotech Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024)
11.4.5 Everest Biotech Recent Development
11.5 NSJ Bioreagents
11.5.1 NSJ Bioreagents Company Detail
11.5.2 NSJ Bioreagents Business Overview
11.5.3 NSJ Bioreagents Tachykinin Receptor 1 Antibody Introduction
11.5.4 NSJ Bioreagents Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024)
11.5.5 NSJ Bioreagents Recent Development
11.6 ProSci
11.6.1 ProSci Company Detail
11.6.2 ProSci Business Overview
11.6.3 ProSci Tachykinin Receptor 1 Antibody Introduction
11.6.4 ProSci Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024)
11.6.5 ProSci Recent Development
11.7 Cusabio
11.7.1 Cusabio Company Detail
11.7.2 Cusabio Business Overview
11.7.3 Cusabio Tachykinin Receptor 1 Antibody Introduction
11.7.4 Cusabio Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024)
11.7.5 Cusabio Recent Development
11.8 FineTest
11.8.1 FineTest Company Detail
11.8.2 FineTest Business Overview
11.8.3 FineTest Tachykinin Receptor 1 Antibody Introduction
11.8.4 FineTest Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024)
11.8.5 FineTest Recent Development
11.9 GeneTex
11.9.1 GeneTex Company Detail
11.9.2 GeneTex Business Overview
11.9.3 GeneTex Tachykinin Receptor 1 Antibody Introduction
11.9.4 GeneTex Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024)
11.9.5 GeneTex Recent Development
11.10 Santa Cruz Biotechnology
11.10.1 Santa Cruz Biotechnology Company Detail
11.10.2 Santa Cruz Biotechnology Business Overview
11.10.3 Santa Cruz Biotechnology Tachykinin Receptor 1 Antibody Introduction
11.10.4 Santa Cruz Biotechnology Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024)
11.10.5 Santa Cruz Biotechnology Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Tachykinin Receptor 1 Antibody Introduction
11.11.4 Merck Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024)
11.11.5 Merck Recent Development
11.12 Atlas Antibodies
11.12.1 Atlas Antibodies Company Detail
11.12.2 Atlas Antibodies Business Overview
11.12.3 Atlas Antibodies Tachykinin Receptor 1 Antibody Introduction
11.12.4 Atlas Antibodies Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024)
11.12.5 Atlas Antibodies Recent Development
11.13 Proteintech
11.13.1 Proteintech Company Detail
11.13.2 Proteintech Business Overview
11.13.3 Proteintech Tachykinin Receptor 1 Antibody Introduction
11.13.4 Proteintech Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024)
11.13.5 Proteintech Recent Development
11.14 Boster Biological Technology
11.14.1 Boster Biological Technology Company Detail
11.14.2 Boster Biological Technology Business Overview
11.14.3 Boster Biological Technology Tachykinin Receptor 1 Antibody Introduction
11.14.4 Boster Biological Technology Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024)
11.14.5 Boster Biological Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Tachykinin Receptor 1 Antibody Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Polyclonal
Table 3. Key Players of Monoclonal
Table 4. Global Tachykinin Receptor 1 Antibody Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Tachykinin Receptor 1 Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Tachykinin Receptor 1 Antibody Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Tachykinin Receptor 1 Antibody Market Share by Region (2019-2024)
Table 8. Global Tachykinin Receptor 1 Antibody Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Tachykinin Receptor 1 Antibody Market Share by Region (2025-2030)
Table 10. Tachykinin Receptor 1 Antibody Market Trends
Table 11. Tachykinin Receptor 1 Antibody Market Drivers
Table 12. Tachykinin Receptor 1 Antibody Market Challenges
Table 13. Tachykinin Receptor 1 Antibody Market Restraints
Table 14. Global Tachykinin Receptor 1 Antibody Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Tachykinin Receptor 1 Antibody Market Share by Players (2019-2024)
Table 16. Global Top Tachykinin Receptor 1 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tachykinin Receptor 1 Antibody as of 2023)
Table 17. Ranking of Global Top Tachykinin Receptor 1 Antibody Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Tachykinin Receptor 1 Antibody Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Tachykinin Receptor 1 Antibody Product Solution and Service
Table 21. Date of Enter into Tachykinin Receptor 1 Antibody Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tachykinin Receptor 1 Antibody Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Tachykinin Receptor 1 Antibody Revenue Market Share by Type (2019-2024)
Table 25. Global Tachykinin Receptor 1 Antibody Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Tachykinin Receptor 1 Antibody Revenue Market Share by Type (2025-2030)
Table 27. Global Tachykinin Receptor 1 Antibody Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Tachykinin Receptor 1 Antibody Revenue Market Share by Application (2019-2024)
Table 29. Global Tachykinin Receptor 1 Antibody Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Tachykinin Receptor 1 Antibody Revenue Market Share by Application (2025-2030)
Table 31. North America Tachykinin Receptor 1 Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Tachykinin Receptor 1 Antibody Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Tachykinin Receptor 1 Antibody Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Tachykinin Receptor 1 Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Tachykinin Receptor 1 Antibody Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Tachykinin Receptor 1 Antibody Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Tachykinin Receptor 1 Antibody Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Tachykinin Receptor 1 Antibody Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Tachykinin Receptor 1 Antibody Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Tachykinin Receptor 1 Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Tachykinin Receptor 1 Antibody Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Tachykinin Receptor 1 Antibody Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Tachykinin Receptor 1 Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Tachykinin Receptor 1 Antibody Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Tachykinin Receptor 1 Antibody Market Size by Country (2025-2030) & (US$ Million)
Table 46. LSBio Company Detail
Table 47. LSBio Business Overview
Table 48. LSBio Tachykinin Receptor 1 Antibody Product
Table 49. LSBio Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024) & (US$ Million)
Table 50. LSBio Recent Development
Table 51. Advanced Targeting Solutions Company Detail
Table 52. Advanced Targeting Solutions Business Overview
Table 53. Advanced Targeting Solutions Tachykinin Receptor 1 Antibody Product
Table 54. Advanced Targeting Solutions Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024) & (US$ Million)
Table 55. Advanced Targeting Solutions Recent Development
Table 56. United States Biological Company Detail
Table 57. United States Biological Business Overview
Table 58. United States Biological Tachykinin Receptor 1 Antibody Product
Table 59. United States Biological Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024) & (US$ Million)
Table 60. United States Biological Recent Development
Table 61. Everest Biotech Company Detail
Table 62. Everest Biotech Business Overview
Table 63. Everest Biotech Tachykinin Receptor 1 Antibody Product
Table 64. Everest Biotech Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024) & (US$ Million)
Table 65. Everest Biotech Recent Development
Table 66. NSJ Bioreagents Company Detail
Table 67. NSJ Bioreagents Business Overview
Table 68. NSJ Bioreagents Tachykinin Receptor 1 Antibody Product
Table 69. NSJ Bioreagents Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024) & (US$ Million)
Table 70. NSJ Bioreagents Recent Development
Table 71. ProSci Company Detail
Table 72. ProSci Business Overview
Table 73. ProSci Tachykinin Receptor 1 Antibody Product
Table 74. ProSci Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024) & (US$ Million)
Table 75. ProSci Recent Development
Table 76. Cusabio Company Detail
Table 77. Cusabio Business Overview
Table 78. Cusabio Tachykinin Receptor 1 Antibody Product
Table 79. Cusabio Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024) & (US$ Million)
Table 80. Cusabio Recent Development
Table 81. FineTest Company Detail
Table 82. FineTest Business Overview
Table 83. FineTest Tachykinin Receptor 1 Antibody Product
Table 84. FineTest Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024) & (US$ Million)
Table 85. FineTest Recent Development
Table 86. GeneTex Company Detail
Table 87. GeneTex Business Overview
Table 88. GeneTex Tachykinin Receptor 1 Antibody Product
Table 89. GeneTex Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024) & (US$ Million)
Table 90. GeneTex Recent Development
Table 91. Santa Cruz Biotechnology Company Detail
Table 92. Santa Cruz Biotechnology Business Overview
Table 93. Santa Cruz Biotechnology Tachykinin Receptor 1 Antibody Product
Table 94. Santa Cruz Biotechnology Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024) & (US$ Million)
Table 95. Santa Cruz Biotechnology Recent Development
Table 96. Merck Company Detail
Table 97. Merck Business Overview
Table 98. Merck Tachykinin Receptor 1 Antibody Product
Table 99. Merck Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024) & (US$ Million)
Table 100. Merck Recent Development
Table 101. Atlas Antibodies Company Detail
Table 102. Atlas Antibodies Business Overview
Table 103. Atlas Antibodies Tachykinin Receptor 1 Antibody Product
Table 104. Atlas Antibodies Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024) & (US$ Million)
Table 105. Atlas Antibodies Recent Development
Table 106. Proteintech Company Detail
Table 107. Proteintech Business Overview
Table 108. Proteintech Tachykinin Receptor 1 Antibody Product
Table 109. Proteintech Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024) & (US$ Million)
Table 110. Proteintech Recent Development
Table 111. Boster Biological Technology Company Detail
Table 112. Boster Biological Technology Business Overview
Table 113. Boster Biological Technology Tachykinin Receptor 1 Antibody Product
Table 114. Boster Biological Technology Revenue in Tachykinin Receptor 1 Antibody Business (2019-2024) & (US$ Million)
Table 115. Boster Biological Technology Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tachykinin Receptor 1 Antibody Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Tachykinin Receptor 1 Antibody Market Share by Type: 2023 VS 2030
Figure 3. Polyclonal Features
Figure 4. Monoclonal Features
Figure 5. Global Tachykinin Receptor 1 Antibody Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Tachykinin Receptor 1 Antibody Market Share by Application: 2023 VS 2030
Figure 7. Flow Cytometry Case Studies
Figure 8. Immunocytochemistry Case Studies
Figure 9. Immunofluorescence Case Studies
Figure 10. Western Blot Case Studies
Figure 11. Others Case Studies
Figure 12. Tachykinin Receptor 1 Antibody Report Years Considered
Figure 13. Global Tachykinin Receptor 1 Antibody Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Tachykinin Receptor 1 Antibody Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Tachykinin Receptor 1 Antibody Market Share by Region: 2023 VS 2030
Figure 16. Global Tachykinin Receptor 1 Antibody Market Share by Players in 2023
Figure 17. Global Top Tachykinin Receptor 1 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tachykinin Receptor 1 Antibody as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Tachykinin Receptor 1 Antibody Revenue in 2023
Figure 19. North America Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Tachykinin Receptor 1 Antibody Market Share by Country (2019-2030)
Figure 21. United States Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Tachykinin Receptor 1 Antibody Market Share by Country (2019-2030)
Figure 25. Germany Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Tachykinin Receptor 1 Antibody Market Share by Region (2019-2030)
Figure 33. China Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Tachykinin Receptor 1 Antibody Market Share by Country (2019-2030)
Figure 41. Mexico Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Tachykinin Receptor 1 Antibody Market Share by Country (2019-2030)
Figure 45. Turkey Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Tachykinin Receptor 1 Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. LSBio Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2019-2024)
Figure 48. Advanced Targeting Solutions Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2019-2024)
Figure 49. United States Biological Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2019-2024)
Figure 50. Everest Biotech Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2019-2024)
Figure 51. NSJ Bioreagents Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2019-2024)
Figure 52. ProSci Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2019-2024)
Figure 53. Cusabio Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2019-2024)
Figure 54. FineTest Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2019-2024)
Figure 55. GeneTex Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2019-2024)
Figure 56. Santa Cruz Biotechnology Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2019-2024)
Figure 57. Merck Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2019-2024)
Figure 58. Atlas Antibodies Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2019-2024)
Figure 59. Proteintech Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2019-2024)
Figure 60. Boster Biological Technology Revenue Growth Rate in Tachykinin Receptor 1 Antibody Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
